Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Notably, the risk appeared higher in trials studying weight loss indications, with higher doses, and with longer duration of treatment
Turner RC, Cull CA, Frighi V, et al
Semaglutide (marketed as 'Ozempic' and 'Wegovy') and the dual-agonist Tirzepatide ('Mounjaro' and 'Zepbound') are some of today's most talked-about medications, given their unprecedented clinical efficacies across both weight loss and T2D management
Electrolyte imbalances Closely related to dehydration, electrolyte imbalancesparticularly low levels of sodium, potassium, and magnesiumcan cause cramping and body aches
People who are older, have kidney or liver issues, or take multiple medications may need slower titration
The most severe documented case involved a 35-year-old female who developed rhabdomyolysis while on tirzepatide
